Release Date: 29/06/12 14:52 Summary: Option Issue and Appendix 3B Price Sensitive: No Download Document 634.15KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%